Open access · OA
via OpenAlex
Association of aberrant DNA methylation with clinicopathological features in breast cancer
Oncology Reports · 2011 · ▲ 51 citations
Abstract
Aberrant DNA methylation is responsible for the epigenetic silencing of genes associated with tumourigenesis and progression of cancer. In this study, we assessed the methylation status of eight genes in 49 snap-frozen primary breast tumours. Epigenetic alterations of 8 genes were analysed with methylation-specific polymerase chain reaction (MS-PCR) (DCR1, DAPK1, RASSF1A and DCR2) or methylation-sensitive high-resolution melting analysis (MS-HRM) (APC, MGMT, GSTP1 and PTEN). MS-HRM performance was validated by bisulfite pyrosequencing regarding the methylation levels of MGMT. Promoter methylation was observed in APC 54.34%, 40.4% DCR1, 37.5% DAPK1, 33.3% RASSF1A, 22.44% MGMT, 16.6% GSTP1, 6% PTEN and 0% DCR2 promoters, respectively. Interestingly, 37 out of 49 cases (75.5%) displayed aberrant promoter methylation in at least one gene. An association of MGMT promoter methylation with age and tumour grade was recorded. Moreover, a correlation with advanced T-category was elicited for GSTP1, RASSF1 and DAPK1 promoter methylation. Finally, concurrent methylation of several genes showed a marginal statistical relationship with N-category. We conclude that APC, DCR1, DAPK1 and RASSF1A promoter methylation represents a common event in breast cancer tumourigenesis. Our results suggest that GSTP1, RASSF1, DAPK1 and MGMT may be implicated in the acquisition of a more aggressive phenotype in breast cancer.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3892/or.2011.1576
- Canonical
- link ↗
- Fetched
- 2026-06-03 MST
Cite this
APA
Tserga, A. (2011). Association of aberrant DNA methylation with clinicopathological features in breast cancer. <em>Oncology Reports</em>. https://doi.org/10.3892/or.2011.1576
Vancouver
Tserga A. Association of aberrant DNA methylation with clinicopathological features in breast cancer. Oncology Reports. 2011. doi:10.3892/or.2011.1576.
BibTeX
@article{aggeliki2011Associ,
title = {Association of aberrant DNA methylation with clinicopathological features in breast cancer},
author = {Aggeliki Tserga},
journal = {Oncology Reports},
year = {2011},
doi = {10.3892/or.2011.1576},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PubMed 2002
Preprint
Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.
PLoS ONE 2015
Open access · CC-BY
Quantitative DNA Methylation Analysis of Candidate Genes in Cervical Cancer
npj Aging 2026
Open access · CC-BY
How epigenetic clocks tick: unpacking the black box by deciphering biological pathways and transcriptomic signatures of accelerated aging
npj aging 2026
Open access · OA
How epigenetic clocks tick: unpacking the black box by deciphering biological pathways and transcriptomic signatures of accelerated aging.
European Journal of Cancer 2017
Open access · OA
DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility
Bone 2019
Preprint · OA